I just heard Hillary speak and she said she wants to help black people? Which is it, Hillary?
The Clinton Health Access Initiative, part of larger foundation, of course, was distributing medications to the terminally ill in Africa. A company called Ranbaxy was in charge of the distribution, and when their practices were exposed as being corrupt (shocking details below,) they were fined $500 million dollars by the Department of Justice.
Question #1: Why weren’t the Clintons mentioned in any of the scandal?
Ranbaxy was eventually found guilty in 2013 on seven counts with intent to defraud and the introduction of adulterated drugs into interstate commerce. The DOJ also levied a $500 million fine and forfeiture against the company. So, one wonders why the Clintons were not also looked into and questioned on all of this.
“This is the largest false claims case ever prosecuted in the District of Maryland, and the nation’s largest financial penalty paid by a generic pharmaceutical company,” said US Attorney for the District of Maryland Rod J. Rosenstein when Ranbaxy pleaded guilty.
The Daily Caller reports:
Former President Bill Clinton and his Clinton Health Access Initiative (CHAI) distributed “watered-down” HIV/AIDs drugs to patients in sub-Saharan Africa, and “likely increased” the risks of morbidity and mortality, according to a draft congressional report obtained by The Daily Caller News Foundation.
The congressional report, titled,“The Clinton Foundation and The India Success Story,” was initiated by Rep. Marsha Blackburn, a Tennessee Republican and vice-chair of the House Energy and Commerce Committee.
The CHAI program to help AIDS victims is considered one of the Clinton Foundation’s most important contributions and is probably its best known initiative.
The congressional report focused on Clinton’s decade-long relationship with a controversial Indian drug manufacturer called Ranbaxy, which CHAI used as one of its main distributors of HIV/AIDS drugs to Third World countries.
It also highlighted the work of Dinesh Thakur, a former Ranbaxy employee who became a star whistleblower, permitting the U.S. government to launch a landmark lawsuit against the Indian firm. The company was vulnerable to U.S. prosecution because it also sold its generic drugs on the U.S. market.
Ranbaxy ultimately pleaded guilty in 2013 to seven criminal counts with intent to defraud and the introduction of adulterated drugs into interstate commerce.
The Department of Justice further levied a $500 million fine and forfeiture on the company.
“This is the largest false claims case ever prosecuted in the District of Maryland, and the nation’s largest financial penalty paid by a generic pharmaceutical company,” said U.S. Attorney for the District of Maryland Rod J. Rosenstein when Ranbaxy pleaded guilty.
“When companies sell adulterated drugs, they undermine the integrity of the FDA’s approval process and may cause patients to take drugs that are substandard, ineffective, or unsafe,” said Stuart F. Delery, acting assistant attorney general for the civil division of the Department of Justice, when the government announced its action against the Indian company.
More Details Are Available At The Daily Caller
With everything going on in this crazy election, one would think this issue would have been exposed before now? Perhaps, the truth always comes out, it just waits until the right time.